Abstract 4371800: 37,500 man-years of clinical expertise validate the cardio-metabolic benefits of empagliflozin-linagliptin in type 2 diabetes: findings from the amplified consensus
Year: 2025
Type: conference-abstract
Source: Circulation
Authors: Tiny Nair, Sushil Gupta, Ameya Joshi, Shehla Shaikh, Jayagopal B, Kaushik Pandit, D Sharma, Krishna Seshadri, Sridhar S, P Jabbar, saumitra ray, PRAKASH Hazra
Institutions: Sanjay Gandhi Post Graduate Institute of Medical Sciences, Bhaktivedanta Hospital & Research Institute, Saifee Hospital, Institute of Post Graduate Medical Education and Research, Apollo Hospitals, Madras Institute of Orthopaedics and Traumatology, Government Medical College, Manipal Hospital
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415793023